Obamacare subsidy cut-off would raise insurance prices: study
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[WASHINGTON] A threat by President Donald Trump to eliminate a crucial subsidy for Obamacare would sharply force up insurance costs and expand the US deficit, an independent government study said on Tuesday.
The Congressional Budget Office said Trump's threat to kill his predecessor's popular health care programme by eliminating the government's funding of "cost-sharing reductions" (CSR) for low-income Americans would force insurers to jack up premium prices by 20 per cent to cover CSRs.
The higher prices could push consumers out of individual insurance markets, making the markets less attractive to insurers as well.
Without the subsidy, the CBO said, "about five per cent of people live in areas that would have no insurers in the non-group market in 2018."
President Barack Obama's Affordable Care Act, which sought to expand health insurance coverage, offered CSRs to people and families earning 250 per cent or less of the federal poverty level, which stands at US$24,600 a year for a family of four.
The subsidy reduces or eliminates their co-pays and out-of-pocket expenses for health treatment.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
In a quirk of the ACA, the CRS subsidies have to be regularly renewed. Worries are that, after the July 28 failure of the Republican-controlled Congress to replace to repeal and replace Obamacare as Mr Trump demanded, he could move to undermine the programme by not renewing the subsidies at the end of this month.
"As I said from the beginning, let Obamacare implode," he tweeted at the time.
AFP
Share with us your feedback on BT's products and services
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant